Some drug, but probably not enough, got through For AOD9604, large molecule size wouldnt have reduced bioavailability to zero, and the use of polyethylene glycol as an excipient may have increased bioavailability slightly13, however there is the distinct possibility that not enough of the drug got through the gastrointestinal tract to make a therapeutic difference. In summation: Given the stark contrast between the biohackers and the institutional scientists, we have the selective release of fats from the fat cells in obese or lean individuals (depending on who you ask) to justify using AOD-9604 for biohacking weight loss
The bacterium is found on the skin of up to 90% of eczema patients, compared to roughly 5% of healthy individuals
The body absorbs only as much B12 as it needs, and any excess is eliminated naturally
United States: Dihexa is not classified as a prescription drug, dietary supplement, or approved therapy
Peptide before and after tracking helps document progress objectively
Dosing protocols vary widely across studies, ranging from micrograms to milligrams depending on route and intended outcome